Health and Fitness Health and Fitness
Mon, September 20, 2010
[ Mon, Sep 20th 2010 ] - Market Wire
ZIOPHARM Oncology to Present at the JMP Healthcare Conference
[ Mon, Sep 20th 2010 ] - Market Wire
Health Net Selected as a Top Military Spouse Friendly Employer
[ Mon, Sep 20th 2010 ] - Market Wire
Orthovita Announces Publication of 24-Month Data .. l Pilot Studies in Vertebroplasty and Kyphoplasty
[ Mon, Sep 20th 2010 ] - Market Wire
St. Jude Medical annuncia la?approvazione in Euro .. ima generazione Athena per la gestione della tera
[ Mon, Sep 20th 2010 ] - Market Wire
St. Jude Medical gibt europische Zulassung des At .. en Generation zum Management von Tiefenhirnstimul
[ Mon, Sep 20th 2010 ] - Market Wire
Celldex Therapeutics Announces Initiation of Rand .. inical Trial of CDX-011 in Advanced Breast Cancer
[ Mon, Sep 20th 2010 ] - Market Wire
LifePoint Hospitals, Inc. Announces Proposed Offering of $400 Million of Senior Notes
[ Mon, Sep 20th 2010 ] - Market Wire
Micromet Initiates Phase 2 Trial of Blinatumomab .. Relapsed/Refractory Acute Lymphoblastic Leukemia
[ Mon, Sep 20th 2010 ] - Market Wire
Celera Signs Agreement with Abbott for Distributi .. Identify Patients at Risk of Coronary Heart Disea
[ Mon, Sep 20th 2010 ] - Market Wire
Micromet Initiates European Pivotal Trial of Blin .. Adult Patients with Acute Lymphoblastic Leukemia
[ Mon, Sep 20th 2010 ] - Market Wire
Prestige Brands Holdings, Inc. Announces Agreement to Acquire Blacksmith Brands
[ Mon, Sep 20th 2010 ] - Market Wire
24-Week Phase 3 Study Found Investigational Drug .. ylated Hemoglobin (HbA1c) When Added to Glimepiri
Fri, September 17, 2010
[ Fri, Sep 17th 2010 ] - Market Wire
UnitedHealth Group, Humana, HealthSpring and Universal American
[ Fri, Sep 17th 2010 ] - Market Wire
Ramius Sends Letter to Independent Board Members of Cypress
[ Fri, Sep 17th 2010 ] - Market Wire
Emergent BioSolutions Awarded HHS Contract Valued .. to $186.6 Million to Develop rPA Anthrax Vaccine
[ Fri, Sep 17th 2010 ] - Market Wire
Medtronic Showcases Cardiovascular Devices at TCT 2010
[ Fri, Sep 17th 2010 ] - Market Wire
Newly Published Data Show Occipital Nerve Stimula .. y Be a Promising New Therapy for Chronic Migraine
[ Fri, Sep 17th 2010 ] - Market Wire
AUSTRALIA';S CANBERRA HOSPITAL UNVEILS IMRISneuro SUITE
[ Fri, Sep 17th 2010 ] - Market Wire
CytoGenix, Inc. Initiates Ferret Testing Expecting Positive Results for Avian Flu Vaccine Study
[ Fri, Sep 17th 2010 ] - Market Wire
Health Net Sponsors the 3rd National Veterans Summer Sports Clinic in San Diego
[ Fri, Sep 17th 2010 ] - Market Wire
Response Genetics, Inc. Settles Proxy Contest With Special Situations Fund
[ Fri, Sep 17th 2010 ] - Market Wire
Ligand Enters into Agreement with Proximagen for CXCR4 Target
[ Fri, Sep 17th 2010 ] - Market Wire
Data to Be Presented at ERS Conference Highlights .. enefit Cystic Fibrosis Patients on Minimal Pharma
Thu, September 16, 2010
[ Thu, Sep 16th 2010 ] - Market Wire
Elan Board Unanimously Accepts McKenna Long Report
[ Thu, Sep 16th 2010 ] - Market Wire
Law Offices of Howard G. Smith Announces Investig .. on Behalf of Shareholders of China-Biotics, Inc.
[ Thu, Sep 16th 2010 ] - Market Wire
DaVita Kicks off Fourth Annual 240-Mile Tour DaVita in Tacoma
[ Thu, Sep 16th 2010 ] - Market Wire
Alkermes Announces FDA Advisory Committee Recommends Approval of VIVITROL® for Opioid Dependence
[ Thu, Sep 16th 2010 ] - Market Wire
Osiris Therapeutics to Present at UBS Global Life Sciences Conference
[ Thu, Sep 16th 2010 ] - Market Wire
Community Health Systems Announces New 4 Million Share Open Market Share Repurchase
[ Thu, Sep 16th 2010 ] - Market Wire
Human Genome Sciences Invites Investors to Listen .. cast of Presentation at UBS Healthcare Conference

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at UBS Healthcare Conference


Published on 2010-09-16 13:15:54 - Market Wire
  Print publication without navigation


ROCKVILLE, Md.--([ BUSINESS WIRE ])--Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that its presentation at the UBS 2010 Global Life Sciences Conference will be webcast and may be accessed at [ www.hgsi.com ].

A member of Human Genome Sciencesa™ senior management team will present a corporate overview on Monday, September 20, 2010, at 11:30 AM Eastern. Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The archive of the webcast will be available for several days after the live event.

About Human Genome Sciences

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.

For more information about HGS, please visit the Companya™s web site at [ www.hgsi.com ]. Health professionals and patients interested in clinical trials of HGS products may inquire via e-mail to [ medinfo@hgsi.com ] or by calling HGS at (877) 822-8472.

HGS and Human Genome Sciences are trademarks of Human Genome Sciences, Inc.

Contributing Sources